Project Grant R21DA061547
Award Date
7/15/24
Completion Date
6/30/26
Dollars Obligated
$693K
Federal Agency
National Institute on Drug Abuse
Awardee
Duke University (TP7EK8DZV6N5)
Federal Grant Program
93.279
Assistance Type
Project Grant
Place of Performance
Durham, NC 27715, USA
Similar Awards
The National Institute on Drug Abuse (NIDA) has awarded a $492,000 Project Grant (CFDA 93.279 - Drug Use and Addiction Research Programs) to the University of Chicago to conduct a multidimensional study on the genetic and epigenetic factors underlying cocaine addiction. The 5-year project aims to: Perform high-resolution chromatin accessibility and DNA methylation profiling to delineate cell-type and circuit-specific epigenetic changes following cocaine self-administration in mice. This will...
This $180,646 Project Grant awarded by the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), will support research to investigate the molecular mechanisms underlying astrocytic CREB's regulation of cocaine drug-seeking behavior. The principal investigator will build an independent research program to elucidate the transcriptional and epigenetic regulation of astrocytes in the context of drug abuse and addiction. Key activities include...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Federal Grant Program 93.279 "Drug Use and Addiction Research Programs," provides $1,996,709.00 over a 5-year period from September 30, 2024 to May 31, 2029. The primary focus of the project is to investigate the role of cortical excitatory projections in cocaine addiction. The key objectives are to: 1) examine the excitability of cortical pyramidal neurons in the supplementary motor cortex (M2)...
This $272,395 Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) aims to develop new methods for targeting the G9A/GLP chromatin-modifying enzyme complex to treat stimulant addiction. The key products and services to be delivered under this 4-year award (04/15/2025 - 03/31/2027) include: Identifying the molecular surfaces and mechanisms that enable specific manipulation of the G9A/GLP enzyme dimers and their...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), will support research by Vanderbilt University to investigate the neural mechanisms underlying inflexible habitual behaviors following chronic cocaine use. The $136,929 award, valid from April 1, 2025 to March 31, 2027, will enable the researcher to: 1) examine how a history of cocaine self-administration alters dopamine release and promotes habitual...
This federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $174,029.99 to the University of California, Irvine to investigate the role of the gene GILZ in regulating cocaine-induced cellular activity and cocaine-associated memory formation. The research aims to test the hypothesis that GILZ, an X-linked gene, acts in the nucleus accumbens to regulate transcription underlying cellular and behavioral...
This $232,128 Project Grant awarded by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) will fund research to investigate the role of dopaminergic and glutamatergic mechanisms in the basolateral amygdala (BLA) in driving dynamic drug-seeking behaviors. The project aims to 1) measure in vivo dopamine signaling and activity of D1-neurons in the BLA during cocaine self-administration, and 2) examine how binge-like cocaine use impacts the...
This federal Project Grant award, provided by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), aims to investigate the interplay between drug-induced long-term synaptic proteomic adaptations and underlying transcriptional responses within the brain's reward regions. The $180,606 award, with a performance period from April 1, 2025 to March 31, 2030, will support research conducted by the Icahn School of Medicine at Mount Sinai to...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $157,568 to Drexel University to elucidate corticolimbic circuit and neuroimmune mechanisms underlying HIV-induced dysregulation of reward-seeking behavior. The research aims to use optogenetic and chemogenetic techniques to stimulate the infralimbic cortex-nucleus accumbens shell circuit and modulate microglial function to rescue HIV-induced...
This federal Project Grant award, provided by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), supports research to characterize the functions of several transcript variants of the DRD3 gene, which encodes the dopamine D3 receptor, and their roles in regulating cocaine-seeking and taking behavior. The $189,644 award to Wake Forest University Health Sciences will fund two phases of research. In the initial R21 phase, the researchers...